Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
BGMD similar filings
- 31 Mar 16 Results of Operations and Financial Condition
- 4 Feb 16 Departure of Directors or Certain Officers
- 23 Dec 15 BG Medicine Withdraws 510(k) Premarket Notification for Proposed Additional Indication for the BGM Galectin-3® Test
- 4 Dec 15 Changes in Registrant's Certifying Accountant
- 30 Nov 15 License and Distribution Agreement Amended
- 23 Nov 15 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- 20 Nov 15 Departure of Directors or Certain Officers
Filing view
External links
Exhibit 16.1
December 4, 2015
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549-7561
Dear Sirs/Madams:
We have read Item 4.01(a) of BG Medicine, Inc.’s Form 8-K dated December 4, 2015, and we agree with the statements made therein.
Yours truly,
/s/ DELOITTE & TOUCHE LLP
Boston, Massachusetts